<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-marinedrugs-17-00567">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grooms</surname>
    <given-names>T.N.</given-names>
   </name>
   <name>
    <surname>Vuong</surname>
    <given-names>H.R.</given-names>
   </name>
   <name>
    <surname>Tyo</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Malik</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Sims</surname>
    <given-names>L.B.</given-names>
   </name>
   <name>
    <surname>Whittington</surname>
    <given-names>C.P.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Matoba</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Steinbach-Rankins</surname>
    <given-names>J.M.</given-names>
   </name>
  </person-group>
  <article-title>Griffithsin-modified electrospun fibers as a delivery scaffold to prevent HIV infection</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2016</year>
  <volume>60</volume>
  <fpage>6518</fpage>
  <lpage>6531</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00956-16</pub-id>
  <pub-id pub-id-type="pmid">27550363</pub-id>
 </element-citation>
</ref>
